Literature DB >> 26095779

Radio-immunotherapy: the focused beam expands.

Benjamin Frey1, Udo S Gaipl2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26095779     DOI： 10.1016/S1470-2045(15)00055-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  8 in total

1.  Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse.

Authors:  Valerio Nardone; Cirino Botta; Michele Caraglia; Elodia Claudia Martino; Maria Raffaella Ambrosio; Tommaso Carfagno; Paolo Tini; Leonardo Semeraro; Gabriella Misso; Anna Grimaldi; Mariarosaria Boccellino; Gaetano Facchini; Massimiliano Berretta; Gianluca Vischi; Bruno Jim Rocca; Aurora Barone; Pierfrancesco Tassone; Pierosandro Tagliaferri; Maria Teresa Del Vecchio; Luigi Pirtoli; Pierpaolo Correale
Journal:  Cancer Biol Ther       Date:  2016-11       Impact factor: 4.742

Review 2.  Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies.

Authors:  Michael Rückert; Lisa Deloch; Rainer Fietkau; Benjamin Frey; Markus Hecht; Udo S Gaipl
Journal:  Strahlenther Onkol       Date:  2018-03-02       Impact factor: 3.621

3.  The dual role of NK cells in antitumor reactions triggered by ionizing radiation in combination with hyperthermia.

Authors:  Patrick Finkel; Benjamin Frey; Friederike Mayer; Karina Bösl; Nina Werthmöller; Andreas Mackensen; Udo S Gaipl; Evelyn Ullrich
Journal:  Oncoimmunology       Date:  2016-06-07       Impact factor: 8.110

4.  The Interplay between Radioresistant Caco-2 Cells and the Immune System Increases Epithelial Layer Permeability and Alters Signaling Protein Spectrum.

Authors:  Jacopo Morini; Gabriele Babini; Sofia Barbieri; Giorgio Baiocco; Andrea Ottolenghi
Journal:  Front Immunol       Date:  2017-03-03       Impact factor: 7.561

5.  A Co-culture Method to Investigate the Crosstalk Between X-ray Irradiated Caco-2 Cells and PBMC.

Authors:  Gabriele Babini; Jacopo Morini; Sofia Barbieri; Giorgio Baiocco; Giovanni Battista Ivaldi; Marco Liotta; Paola Tabarelli de Fatis; Andrea Ottolenghi
Journal:  J Vis Exp       Date:  2018-01-30       Impact factor: 1.355

6.  Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial.

Authors:  Yijun Hua; Rui You; Zhiqiang Wang; Peiyu Huang; Mei Lin; Yanfeng Ouyang; Yulong Xie; Xiong Zou; Youping Liu; Chongyang Duan; Yonglong Liu; Chenmei Gu; Rongzeng Liu; Qi Yang; Rou Jiang; Mengxia Zhang; Xi Ding; Siyuan Chen; Chao Lin; Rui Sun; Mingyuan Chen
Journal:  J Immunother Cancer       Date:  2021-11       Impact factor: 13.751

Review 7.  Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications.

Authors:  Anja Derer; Lisa Deloch; Yvonne Rubner; Rainer Fietkau; Benjamin Frey; Udo S Gaipl
Journal:  Front Immunol       Date:  2015-10-08       Impact factor: 7.561

Review 8.  Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation.

Authors:  Lisa Deloch; Anja Derer; Josefin Hartmann; Benjamin Frey; Rainer Fietkau; Udo S Gaipl
Journal:  Front Oncol       Date:  2016-06-20       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.